Literature DB >> 1898270

Platelet aggregation induced by uncommon serotypes of Streptococcus sanguis isolated from patients with Behçet's disease.

E Isogai1, H Isogai, K Yokota, S Hayashi, N Fujii, K Oguma, K Yoshikawa, Y Sasamoto, S Kotake, S Ohno.   

Abstract

Uncommon serotypes were tested for their ability to induce aggregation in platelet-rich plasma. Both uncommon and common serotypes induced platelet aggregation in rabbit platelet-rich plasma, but serotonin release was higher with the uncommon serotypes. Aggregation at ATP release varied between uncommon and common serotypes. With human platelet-rich plasma, only uncommon serotypes showed aggregation. Differences in serotype selectivity and the rate of aggregation were noted among platelet donors. About half of the patients with Behçet's disease and 30% of health controls showed platelet aggregation. Plasma from non-responder patients with Behçet's disease inhibited aggregation of healthy responder platelets within 20 min. Thus selective binding of uncommon serotypes of Strep. sanguis to platelets might cause the vasculitis in Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898270     DOI: 10.1016/0003-9969(91)90132-e

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  3 in total

Review 1.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

2.  The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.

Authors:  Ayşe İlksen Colpak; Umut Kalyoncu; Yasemin Gürsoy Özdemir
Journal:  Noro Psikiyatr Ars       Date:  2014-06-01       Impact factor: 1.339

3.  The role of an uncommon type of oral streptococcus sanguis in the etiology of behcet's disease.

Authors:  M Tsuchida; S Mineshita; H Okonogi; K Sugimori; K Hoshi; T Horiuchi; L M Wang; E K Fujimoto
Journal:  Environ Health Prev Med       Date:  1997-07       Impact factor: 3.674

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.